Antibody purification strategies — a delicate balance
The purification of antibody products is designed to remove other host cell material and improve performance. But yield, quality and practicality all need to be balanced when selecting a purification strategy. By doing so, a cost-effective purity can be achieved to suit your research or production needs.
At Inotiv, we work with customers to clean, clone and optimize promising cell lines before scaling them up to deliver production quantities of consistent antibodies.
Today, Inotiv delivers: Monoclonal and polyclonal antibody production; Hybridoma development; Immunogenicity immunization; Antibody purification; Mouse antibody production (MAP) testing.
History, strategies & challenges
Download the infographic series
Get the sixth in a series of infographics, charting the history, production strategies and technology challenges faced when producing antibodies for research and manufacture. These resources provide insights collated from Inotiv’s long history in antibody production, with quick reference production strategies and useful reminders of the challenges commonly faced by researchers and production engineers.
